Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza

Completed · Phase 3

Conditions studied: Influenza

In brief

This study will evaluate the safety, pharmacokinetics and effectiveness of a single dose of IV peramivir compared to a standard 5 day course of oral oseltamivir in the treatment of pediatric subjects with acute uncomplicated influenza.

Key facts

Study ID

NCT02369159

Run by

BioCryst Pharmaceuticals

People needed

137

Starts

2015-03-11

Expected to finish

2020-05-14

Last updated by the study team

2021-03-23

Who can join

Age: any, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Peramivir Investigative Site — Shreveport, Louisiana, United States
• Peramivir investigative site — Dayton, Ohio, United States
• Peramivir investigative site — Smithfield, Pennsylvania, United States
• Peramivir Investigative Site — Houston, Texas, United States
• Peramivir investigative site — San Antonio, Texas, United States
• Peramivir investigative site — Splendora, Texas, United States
• Peramivir investigative site — Draper, Utah, United States
• Peramivir investigative site — Salt Lake City, Utah, United States
• Peramivir investigative site — South Jordan, Utah, United States
• Peramivir Investigative Site — Pretoria, South Africa

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.